Serum uric acid as a metabolic regulator of endothelial function in heart failure

Journal Title: Archives of Clinical Hypertension - Year 2017, Vol 3, Issue 1

Abstract

The development of heart failure (HF) associated with elevated level of serum uric acid (SUA). Additionally, the majority of individuals with traditional cardiovascular risk factors contributing in HF risk exhibited increased levels of SUA. Although SUA lowering drugs are widely used in patients with symptomatic hyperuricemia and gout beyond their etiologies, there is no agreement of SUA below target level 6.0 mg/dL in asymptomatic individuals with kidney injury and CV disease and data of ones in heart failure (HF) are sufficiently controversial. First SUA plays an important role in inducing oxidative stress, inflammation, neurohumoral activation, and endothelial dysfunction. Secondary, SUA may act as antioxidant contributing in restoring of vascular function. Moreover, SUA is able to epigenetically regulate a survival of endothelial precursors, mediate their mobbing and differentiation, as well as coordinate a turn-over effect of metabolic memory phenomenon into repair capability of cell precursors. However, elevated SUA level was found a predictor of adverse clinical outcomes of HF. The short communication is depicted the importance of new clinical data to confirm the emerging reparative ability of SUA in HF and its role as promising target for treatment in cardiac failure.

Authors and Affiliations

Berezin Alexander E

Keywords

Related Articles

Ambient Air Pollution and Hypertension: A Relationship that Strikes Around the Clock

Cardiovascular disease is the leading cause of death in the World [1]. As the major risk factor for cardiovascular disease, hypertension has been identified as the most important cause of disability and the leading risk...

Alcoholism, Fibroblast Growth Factor 23 and Cardiovascular Risk

Background: Bone metabolism is tightly regulated by several hormones that are synthesized in bone cells and that have effects not only on bone but on several distant organs. These hormones are involved in intermediate me...

The Correlation Between Arterial Hypertension and Endothelial Function

Arterial hypertension is defined by a stable increase in systemic arterial blood pressure (BP) values, i.e. systolic value of 140 mmHg or more and/or diastolic one of 90 mmHg or more. Its prevalence is about 30–45% of th...

Integration of Home Blood Pressure Monitoring in Hypertension Management

Background: White coat syndrome, masked hypertension, and poor technique may produce inaccurate office-based blood pressure (BP) readings and lead to over diagnosis and over treatment with antihypertensive agents. Nation...

Ambulatory Blood Pressure (BP) and Heart Rate (HR), Gender Differences in Cordoba, Argentina

BP is changing in the course of age, in both sexes, Systolic BP increases continuously and instead Diastolic BP only rises until age 50-60 years and then stabilizes or drops [1]. The % of hypertensive patients in Argent...

Download PDF file
  • EP ID EP554740
  • DOI 10.17352/ach.000016
  • Views 43
  • Downloads 0

How To Cite

Berezin Alexander E (2017). Serum uric acid as a metabolic regulator of endothelial function in heart failure. Archives of Clinical Hypertension, 3(1), 27-29. https://europub.co.uk/articles/-A-554740